Therapeutic Antibodies

  • Image of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Disease Building
  • Image of a person using a pipet

    The CPRIT Therapeutic Antibody Core

    We offer Texas-wide access to specialized technical expertise, instrumentation, and automation to advance lead antibodies with “drug like” properties from academic laboratories to the stage of preclinical development.

  • Image of a microscope stage

    Therapeutic Antibody Development

    Lead Identification – Lead Optimization – Lead Construction – Antibody Production

Researchers have discovered a potential new antibody therapy for COVID-19. (Photo by UTHealth)

New antibody therapies found to potentially fight COVID-19

January 21, 2021 | Jeannette Sanchez

Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.

The first virtual Symposium of the CPRIT Therapeutic Antibody Core

December 11, 2020

The annual symposium of the CPRIT Therapeutic Antibody Core took place on Friday, December 11, 2020, from 1:00 pm Central Time. For the safety of participants during the COVID-19 pandemic, the symposium was held online via WebEx. Speakers highlighted the core’s capacities and provided examples of successful core collaborations.

The 2019 Annual Symposium of the CPRIT Therapeutic Antibody Core

February 26, 2020

The annual symposium of the CPRIT Therapeutic Antibody Core took place on Tuesday, December 10, 2019, at the University of Texas Health Science Center at Houston (UTHealth – Houston). Speakers highlighted the core’s capacities and provided examples of successful core collaborations.